n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with phenylephrine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clapp, LH; O'Brien, AJ; Sibbald, R; Singer, M; Wilson, AJ | 1 |
| Armstrong, SJ; Davidge, ST; Xu, Y | 1 |
| Alonso, MJ; Alvarez, Y; Balfagón, G; Briones, AM; Salaices, M | 1 |
| Briones, AM; Giraldo, J; Montoya, N; Vila, E | 1 |
| Asbun-Bojalil, J; Castillo, EF; Castillo-Henkel, C; Castillo-Hernandez, MC; Guevara-Balcazar, G; Lopez, RM; Lopez-Sanchez, P | 1 |
| Anantharamaiah, GM; Dai, L; Datta, G; Gupta, H; Honavar, J; Modi, S; Palgunachari, M; Patel, R; White, CR; Wyss, JM; Zhang, Z | 1 |
| de Sotomayor, MA; Herrera, MD; Marhuenda, E; Mingorance, C | 1 |
| Cruz, M; García-Macedo, R; Gómez-Zamudio, JH; Ibarra-Barajas, M; Kumate, J; Lázaro-Suárez, M | 1 |
| Botelho, T; de Batista, PR; Padilha, AS; Ribeiro-Júnior, RF; Simões, FV; Vassallo, DV | 1 |
| Brun, BF; Campos-Toimil, M; Dias, AT; Gava, AL; Gil-Longo, J; Leal, MAS; Meyrelles, SS; Pereira, TMC; Porto, ML; Vasquez, EC | 1 |
10 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and phenylephrine
| Article | Year |
|---|---|
Temporal variation in endotoxin-induced vascular hyporeactivity in a rat mesenteric artery organ culture model.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cyclooxygenase 2; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Guanosine Monophosphate; Guanylate Cyclase; Isoenzymes; Lipopolysaccharides; Male; Mesenteric Arteries; Models, Animal; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrobenzenes; Organ Culture Techniques; Penicillamine; Phenylephrine; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Effects of chronic PGHS-2 inhibition on PGHS-dependent vasoconstriction in the aged female rat.
Topics: Animals; Cyclooxygenase Inhibitors; Female; Meclofenamic Acid; Menopause; Mesenteric Arteries; Methacholine Chloride; Models, Animal; Nitrobenzenes; Ovariectomy; Phenylephrine; Prostaglandin-Endoperoxide Synthases; Prostaglandins H; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasoconstrictor Agents; Vasodilator Agents | 2004 |
Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses.
Topics: Animals; Aorta; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Endothelium, Vascular; Hypertension; Male; Nitrobenzenes; Phenylephrine; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides; Vasoconstriction; Vasoconstrictor Agents | 2005 |
Ageing affects nitric oxide synthase, cyclooxygenase and oxidative stress enzymes expression differently in mesenteric resistance arteries.
Topics: Acetylcholine; Aging; Animals; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; In Vitro Techniques; Indomethacin; Male; Mesenteric Arteries; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitrobenzenes; Oxidative Stress; Phenylephrine; Rats; Rats, Sprague-Dawley; Sulfonamides; Up-Regulation; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
The influence of constitutive COX-2 in smooth muscle tissue on the contractile effect of phenylephrine in the rat abdominal aorta.
Topics: Animals; Aorta, Abdominal; Cycloheximide; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Gene Expression Regulation; Immunoblotting; Indomethacin; Muscle Contraction; Muscle, Smooth; Nitrobenzenes; Phenylephrine; Phospholipase A2 Inhibitors; Pyrazoles; Rats; Sulfonamides; Type C Phospholipases | 2010 |
The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats.
Topics: Animals; Apolipoprotein A-I; Blood Pressure; Blood Vessels; Cholesterol, HDL; Cyclooxygenase Inhibitors; Endotoxemia; Hemodynamics; Humans; Indomethacin; Lipopolysaccharides; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrobenzenes; Peptides; Phenylephrine; Random Allocation; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasoconstrictor Agents | 2010 |
Chronic treatment with the cannabinoid 1 antagonist rimonabant altered vasoactive cyclo-oxygenase-derived products on arteries from obese Zucker rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Body Weight; Endothelium, Vascular; Nitric Oxide Synthase Type II; Nitrobenzenes; Obesity; Phenylephrine; Piperidines; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Zucker; Receptor, Cannabinoid, CB1; Rimonabant; Sulfonamides; Tumor Necrosis Factor-alpha; Vasodilation; Vasodilator Agents | 2010 |
Vascular endothelial function is improved by oral glycine treatment in aged rats.
Topics: Acetylcholine; Aging; Animals; Aorta; Cyclooxygenase 1; Cyclooxygenase 2; Endothelium, Vascular; Glycine; Humans; Indomethacin; Interleukin-1beta; Male; NADPH Oxidase 4; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrobenzenes; Phenylephrine; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Superoxide Dismutase; Superoxides; Tumor Necrosis Factor-alpha | 2015 |
Treatment with high dose of atorvastatin reduces vascular injury in diabetic rats.
Topics: Animals; Aorta; Atorvastatin; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Endothelium, Vascular; Indomethacin; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitrobenzenes; Phenylephrine; Prostaglandins; Rats; Rats, Wistar; Streptozocin; Sulfonamides; Superoxides; Vascular System Injuries; Vasodilation; Vasodilator Agents | 2016 |
Sildenafil (Viagra®) Prevents Cox-1/ TXA2 Pathway-Mediated Vascular Hypercontractility in ApoE-/- Mice.
Topics: Animals; Apolipoproteins E; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Endothelium, Vascular; Fatty Acids, Unsaturated; Hydrazines; Interleukin-10; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitrobenzenes; Phenylephrine; Pyrazoles; Receptors, Thromboxane; Sildenafil Citrate; Sulfonamides; Thromboxane A2; Vasoconstriction | 2017 |